The results of the risk analysis showed that carriers of a valine (V)-to-methionine (M) substitution in amino acid 433 of CYP4F2 (CYP4F2*3, G1347A) had increased susceptibility to DKD. Here, CYP4F2 is linked to diabetic kidney disease.